CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation

Jelle de Wit, Yuri Souwer, Astrid J. van Beelen, Rosa de Groot, Femke J. M. Muller, Hanny Klaasse Bos, Tineke Jorritsma, Martien L. Kapsenberg, Esther C. de Jong, S. Marieke van Ham

Research output: Contribution to journalArticleAcademicpeer-review

45 Citations (Scopus)

Abstract

IL-17-producing CD4(+) T helper (Th17) cells are important for immunity against extracellular pathogens and in autoimmune diseases. The factors that drive Th17 development in human remain a matter of debate. Here we show that, compared with classic CD28 costimulation, alternative costimulation via the CD5 or CD6 lymphocyte receptors forms a superior pathway for human Th17-priming. In the presence of the Th17-promoting cytokines IL-1β, IL-6, IL-23, and transforming growth factor-β (TGF-β), CD5 costimulation induces more Th17 cells that produce higher amounts of IL-17, which is preceded by prolonged activation of signal transducer and activator of transcription 3 (STAT3), a key regulator in Th17 differentiation, and enhanced levels of the IL-17-associated transcription factor retinoid-related orphan receptor-γt (ROR-γt). Strikingly, these Th17-promoting signals critically depend on CD5-induced elevation of IL-23 receptor (IL-23R) expression. The present data favor the novel concept that alternative costimulation via CD5, rather than classic costimulation via CD28, primes naive T cells for stable Th17 development through promoting the expression of IL-23R
Original languageEnglish
Pages (from-to)6107-6114
JournalBlood
Volume118
Issue number23
DOIs
Publication statusPublished - 2011

Cite this